FDA Approves Once-Daily Veramyst(TM) (fluticasone furoate) Nasal Spray for Treatment of Seasonal and Year-Round Allergy Symptoms in Adults and Childre

FDA Approves Once-Daily Veramyst(TM) (fluticasone furoate) Nasal Spray for Treatment of Seasonal and Year-Round Allergy Symptoms in Adults and Children as Young as Two Years: "RESEARCH TRIANGLE PARK, N.C., April 27 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration today approved once-daily Veramyst(TM) (fluticasone furoate) Nasal Spray to treat seasonal and year- round allergy symptoms in adults and children two years of age and older. Veramyst will be available by prescription nationwide by late May 2007."